[
    [
        {
            "time": "2019-03-29",
            "original_text": "Lennox International, Inc. (LII) Ex-Dividend Date Scheduled for March 29, 2019",
            "features": {
                "keywords": [
                    "Lennox International",
                    "Ex-Dividend",
                    "Scheduled"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "industrial goods"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-03-29",
            "original_text": "Hurco Companies, Inc. (HURC) Ex-Dividend Date Scheduled for March 29, 2019",
            "features": {
                "keywords": [
                    "Hurco Companies",
                    "Ex-Dividend",
                    "Scheduled"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "industrial goods"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 5,
                "Impact": 3,
                "Duration": 3,
                "Entity_Density": 7,
                "Market_Scope": 3,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2019-01-03",
            "original_text": "Is Biogen a Beat-Up Bargain? And Is Bristol-Myers' Mega-Merger on the Rocks?",
            "features": {
                "keywords": [
                    "Biogen",
                    "Beat-Up Bargain",
                    "Bristol-Myers",
                    "Mega-Merger",
                    "Rocks"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "Correlation": 10,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 7,
                "Time_Proximity": 9,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]